BridgeBio is substantially boosted the progress of an new therapy for ATTR-CM, leveraging the investigational drug. Preliminary trial information suggests significant improvements for patients suffering with the https://attruby430228.thezenweb.com/bridgebio-improves-amyloidosis-management-using-the-therapy-80929263